Squalamine: An Appropriate Strategy against the Emergence of Multidrug Resistant Gram-Negative Bacteria? The Antibiotic of the Future
2008

Squalamine: A Potential Solution for Multidrug Resistant Bacteria

publication Evidence: moderate

Author Information

Author(s): Salmi Chanaz, Loncle Celine, Vidal Nicolas, Letourneux Yves, Fantini Jacques, Maresca Marc, Taïeb Nadira, Pagès Jean-Marie, Brunel Jean Michel

Primary Institution: Unité de Recherche sur les Maladies Infectieuses et Tropicales Émergentes (URMITE), Faculté de Médecine, Université de la Méditerranée, Marseille, France

Hypothesis

Can squalamine effectively combat multidrug resistant Gram-negative bacteria?

Conclusion

Squalamine shows preserved activity against multidrug resistant bacterial pathogens and may serve as an alternative to traditional antibiotics.

Supporting Evidence

  • Squalamine effectively targets the membrane integrity of bacteria.
  • It retains activity against bacteria that are resistant to common antibiotics.
  • Squalamine's mechanism may involve disrupting the outer membrane of Gram-negative bacteria.
  • Alterations in lipopolysaccharide (LPS) can affect squalamine's efficacy but do not eliminate it.
  • Squalamine shows less susceptibility to efflux resistance mechanisms compared to traditional antibiotics.

Takeaway

Squalamine is a special molecule that can help fight superbugs, which are bacteria that don't respond to regular medicines.

Methodology

The study used minimal inhibitory concentration (MIC) tests to evaluate the antimicrobial activity of squalamine against various bacterial strains.

Limitations

The study does not fully elucidate the mechanism of action of squalamine against Gram-negative bacteria.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0002765

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication